Concord Biotech

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE338H01029
NSEID: CONCORDBIO
BSEID: 543960

INR

1,341.00

-5.7 (-0.42%)

BSENSE

Dec 19

BSE+NSE Vol: 45.74 k

{
  "main_header": {
    "sid": 10038977,
    "name": "Concord Biotech",
    "stock_name": "Concord Biotech",
    "full_name": "Concord Biotech Ltd",
    "name_url": "stocks-analysis/concord-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,341.00",
    "chg": -5.7,
    "chgp": "-0.42%",
    "dir": -1,
    "prev_price": "1,346.70",
    "mcapval": "14,247.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543960,
    "symbol": "CONCORDBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE338H01029",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "45.74 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concord-biotech-10038977-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Concord Biotech Stock Falls to 52-Week Low of Rs.1318.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-stock-hits-52-week-low-at-rs131885-amidst-continued-downtrend-3762551",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ConcordBiotech_priceRelatedfactors_3762551.png",
        "date": "2025-12-18 10:17:21",
        "description": "Concord Biotech’s share price reached a new 52-week low of Rs.1318.85 today, marking a significant decline amid subdued market conditions and company-specific performance trends. The stock has been trading below all key moving averages, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Concord Biotech Stock Falls to 52-Week Low of Rs.1318.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-stock-falls-to-52-week-low-of-rs131885-3762548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ConcordBiotech_priceRelatedfactors_3762548.png",
        "date": "2025-12-18 10:17:09",
        "description": "Concord Biotech’s shares reached a fresh 52-week low of Rs.1318.85 today, marking a significant decline amid broader market fluctuations. The stock has been trading below all key moving averages and has recorded losses over the past two sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Concord Biotech Sees Revision in Market Assessment Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3762146",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ConcordBiotech_mojoScore_3762146.png",
        "date": "2025-12-18 10:10:57",
        "description": "Concord Biotech has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment highlights ongoing challenges in profitability and market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Concord Biotech Stock Falls to 52-Week Low of Rs.1325 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-stock-falls-to-52-week-low-of-rs-1325-3761494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ConcordBiotech_priceRelatedfactors_3761494.png",
        "date": "2025-12-17 15:55:04",
        "description": "Concord Biotech’s shares touched a fresh 52-week low of Rs.1325 today, marking a significant decline amid broader market fluctuations and sector underperformance. The stock’s intraday movement reflected a drop of 3.93%, underperforming the Pharmaceuticals & Biotechnology sector by nearly 4%."
      },
      {
        "title": "Concord Biotech Stock Falls to 52-Week Low of Rs.1325",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-stock-falls-to-52-week-low-of-rs-1325-3761493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ConcordBiotech_priceRelatedfactors_3761493.png",
        "date": "2025-12-17 15:55:02",
        "description": "Concord Biotech’s shares reached a fresh 52-week low of Rs.1325 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock underperformed its Pharmaceuticals & Biotechnology sector peers, reflecting ongoing concerns about its recent financial performance and valuation metrics."
      },
      {
        "title": "Concord Biotech Falls to 52-Week Low of Rs.1341.7 Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-stock-falls-to-52-week-low-of-rs13417-3753701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ConcordBiotech_priceRelatedfactors_3753701.png",
        "date": "2025-12-09 10:52:53",
        "description": "Concord Biotech's stock reached a fresh 52-week low of Rs.1341.7 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock has recorded a consecutive two-day fall, reflecting a cumulative return of -3.96% over this period, underperforming its Pharmaceuticals & Biotechnology sector peers."
      },
      {
        "title": "Why is Concord Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-concord-biotech-fallingrising-3752545",
        "imagepath": "",
        "date": "2025-12-09 01:23:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Concord Biotech’s share price hit a fresh 52-week low of ₹1,352.30 during intraday trading on 08-Dec, marking a 3.69% decline from previous levels. The stock underperformed its sector by 1.81% on the day, with a weighted average price indicating that most trading volume occurred near the day’s low. This suggests selling pressure dominated throughout the session. Furthermore, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish trend and weak technical momentum.</p>\n<p>Investor participation has also waned, with delivery volumes on 05-Dec falling by 27.32% compared to the five-day average. Although liquidity remains adequate for moderate trade sizes,..."
      },
      {
        "title": "Concord Biotech Stock Falls to 52-Week Low of Rs 1364",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-stock-falls-to-52-week-low-of-rs1364-3751534",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ConcordBiotech_priceRelatedfactors_3751534.png",
        "date": "2025-12-08 12:54:11",
        "description": "Concord Biotech’s share price reached a fresh 52-week low of Rs 1364 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock’s performance contrasts with the broader Sensex, which remains close to its 52-week high, highlighting the challenges faced by the pharmaceutical and biotechnology company over the past year."
      },
      {
        "title": "Concord Biotech Stock Falls to 52-Week Low of Rs 1364",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-falls-to-52-week-low-of-rs-1364-amidst-continued-underperformance-3751530",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ConcordBiotech_priceRelatedfactors_3751530.png",
        "date": "2025-12-08 12:54:01",
        "description": "Concord Biotech’s shares reached a new 52-week low of Rs 1364 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock’s performance contrasts with the Sensex, which remains close to its 52-week high, highlighting challenges specific to the company within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 337,
    "sid": "10038977",
    "stock_news_url": "https://www.marketsmojo.com/news/concord-biotech-10038977"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30(5) Of The SEBI (LODR) Regulations 2015",
      "datetime": "18-Dec-2025",
      "details": "Change in KMPs Authorization for determining materiality of Event and Information to the Stock Exchanges",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Appointment Of CFO And KMP",
      "datetime": "18-Dec-2025",
      "details": "Appointment of Mr. Raviraj Karia as Chief Financial Officer and KMP",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "18-Dec-2025",
      "details": "Appointment of Mr. Raviraj Karia as CFO and KMP of the company w.e.f. 18/12/2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Concord Biotech Ltd has declared <strong>1070%</strong> dividend, ex-date: 03 Sep 25",
          "dt": "2025-09-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Concord Biotech Stock Falls to 52-Week Low of Rs.1318.85

2025-12-18 10:17:21

Concord Biotech’s share price reached a new 52-week low of Rs.1318.85 today, marking a significant decline amid subdued market conditions and company-specific performance trends. The stock has been trading below all key moving averages, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Concord Biotech Stock Falls to 52-Week Low of Rs.1318.85

2025-12-18 10:17:09

Concord Biotech’s shares reached a fresh 52-week low of Rs.1318.85 today, marking a significant decline amid broader market fluctuations. The stock has been trading below all key moving averages and has recorded losses over the past two sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Concord Biotech Sees Revision in Market Assessment Amidst Challenging Financial Trends

2025-12-18 10:10:57

Concord Biotech has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment highlights ongoing challenges in profitability and market sentiment within the Pharmaceuticals & Biotechnology sector.

Concord Biotech Stock Falls to 52-Week Low of Rs.1325 Amidst Market Pressure

2025-12-17 15:55:04

Concord Biotech’s shares touched a fresh 52-week low of Rs.1325 today, marking a significant decline amid broader market fluctuations and sector underperformance. The stock’s intraday movement reflected a drop of 3.93%, underperforming the Pharmaceuticals & Biotechnology sector by nearly 4%.

Concord Biotech Stock Falls to 52-Week Low of Rs.1325

2025-12-17 15:55:02

Concord Biotech’s shares reached a fresh 52-week low of Rs.1325 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock underperformed its Pharmaceuticals & Biotechnology sector peers, reflecting ongoing concerns about its recent financial performance and valuation metrics.

Concord Biotech Falls to 52-Week Low of Rs.1341.7 Amid Market Pressure

2025-12-09 10:52:53

Concord Biotech's stock reached a fresh 52-week low of Rs.1341.7 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock has recorded a consecutive two-day fall, reflecting a cumulative return of -3.96% over this period, underperforming its Pharmaceuticals & Biotechnology sector peers.

Why is Concord Biotech falling/rising?

2025-12-09 01:23:02

Recent Price Movement and Market Context

Concord Biotech’s share price hit a fresh 52-week low of ₹1,352.30 during intraday trading on 08-Dec, marking a 3.69% decline from previous levels. The stock underperformed its sector by 1.81% on the day, with a weighted average price indicating that most trading volume occurred near the day’s low. This suggests selling pressure dominated throughout the session. Furthermore, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish trend and weak technical momentum.

Investor participation has also waned, with delivery volumes on 05-Dec falling by 27.32% compared to the five-day average. Although liquidity remains adequate for moderate trade sizes,...

Concord Biotech Stock Falls to 52-Week Low of Rs 1364

2025-12-08 12:54:11

Concord Biotech’s share price reached a fresh 52-week low of Rs 1364 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock’s performance contrasts with the broader Sensex, which remains close to its 52-week high, highlighting the challenges faced by the pharmaceutical and biotechnology company over the past year.

Concord Biotech Stock Falls to 52-Week Low of Rs 1364

2025-12-08 12:54:01

Concord Biotech’s shares reached a new 52-week low of Rs 1364 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock’s performance contrasts with the Sensex, which remains close to its 52-week high, highlighting challenges specific to the company within the Pharmaceuticals & Biotechnology sector.